Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Adenosine

(Adenocard)

 

GCEMS Protocol:

 

  • Sustained V-Tach
  • Narrow Complex Tachycardia
  • Ped Unstable Tachycardia

 

INDICATIONS:

 

  • PSVT, SVT

 

DOSAGE:

 

ADULT:

 

  • 12 mg rapid IV /IO bolus inital dose
  • If SVT rhythm has not changed after 5 minutes, may repeat with a second dose of 12 mg rapid IV/IO bolus

 

PEDIATRIC:

 

  • 0.1 mg/kg (over 1 to 2 sec) IV /IO followed by rapid saline flush. Max initial dose 6 mg.
  • 0.2 mg/kg within 1-2 minutes of continuing SVT – given rapid IV/IO bolus. Max single dose 12 mg.

 

CONTRAINDICATIONS:

 

  • Second or third degree A-V block

 

SIDE EFFECTS:

 

  • Short-lasting 2° or 3° AV block
  • Transient Asystole
  • Various arrhythmias lasting only a few seconds